Naoto Fujiwara

19PUBLICATIONS
126CO-AUTHORS
Metabolic medicinePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 14, 2026
A data-driven framework reconstructs the molecular continuum of human MASLD progression.

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

|Oct 08, 2025
Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis.

Masahiko Tameda, Hideaki Tanaka, Yutaka Toyomasu

|Jan 14, 2025
Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic.

Hiroyuki Suzuki, Naoto Fujiwara, Amit G Singal

|Oct 28, 2023
Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma.

Yasuyuki Tamai, Naoto Fujiwara, Takamitsu Tanaka

|Sep 07, 2023
Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer.

Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti

Pageof 4

Frequent Collaborators

10 joint publications

Yujin Hoshida

6 joint publications

Hayato Nakagawa

3 joint publications

Ryosuke Tateishi

3 joint publications

Shijia Zhu